Endothelin-1 in arterial hypertension after cold pressor test. 1997

S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
Institute of Internal and Emergency Medicine, University of Catania, Italy.

BACKGROUND We assessed plasma endothelin-1 (ET-1) concentrations in a group of hypertensive subjects in order to determine the possible presence of a disorder of ET-1 production and release. METHODS A selected cohort of hypertensive subjects was compared with a control group. Plasma levels of ET-1 in baseline conditions and after cold the pressor test (CPT) were measured. All subjects were studied as outpatients. Twenty-one male hypertensive patients were compared with 15 male controls. The hypertensive patients had undergone clinical examinations to rule out the presence of vascular damage. Clinical examination of the controls was performed to rule out hypertension. Patients with essential hypertension were 21 males, age: 57+/-7 years, body mass index 22.3+/-11.2 kg/m2. We assessed plasma ET-1 in baseline conditions and after a cold pressor test. RESULTS Means +/-SD baseline concentrations of ET-1 were 12.47+/-2.41 pg/ml in hypertensives and 8.2+/-3.8 pg/ml in controls (p<0.01). Mean +/-SD post CPT plasma ET-1 was 12.55+/-2.83 pg/ml in hypertensive subjects and 8.6+/-1.9 pg/ml in controls (p<0.01). CPT did not modify plasma ET-1 concentrations in either group. CPT significantly raised arterial pressure only in hypertensive subjects. CONCLUSIONS These results lead us to postulate the presence of a disorder of ET-1 production and release in hypertensive subjects.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
August 1998, The American journal of physiology,
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
June 1978, Angiology,
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
May 1990, Biochemical and biophysical research communications,
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
March 1975, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
January 1975, Bollettino della Societa italiana di cardiologia,
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
April 1998, Journal of glaucoma,
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
January 1984, Hypertension (Dallas, Tex. : 1979),
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
October 1979, Lancet (London, England),
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
December 1979, Lancet (London, England),
S Neri, and C M Bruno, and D Ierna, and S Signorelli, and G Pennisi, and G M Andreozzi
November 1995, Journal of human hypertension,
Copied contents to your clipboard!